Click here for Vyndaqel®▼ (tafamidis) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Detect, differentiate and diagnose: Identifying and managing ATTR-CM
Catch up with our panel of expert speakers from the BCS 2021 as they describe the clinical journey of a patient with ATTR-CM from detection through to diagnosis and management.
Aldactone (spironolactone) 25mg tablets
Aldactone (spironolactone) 50mg tablets
Aldactone (spironolactone) 100mg tablets
Future directions for management of cardiac amyloidosis
Dr Lisa Anderson provides an overview of the diagnosis and early management of cardiac amyloidosis and Dr Robert Cooper discusses the emerging treatment strategies.
A Disease Enigma: Unlocking the Clinical Clues of ATTR-CM
Dr Pablo Garcia-Pavia provides an overview of ATTR-CM and the initial patient presentation. He presents at the live Crack the Code: Unmasking and Addressing ATTR-CM in Your Practice webinar in 2020.
Challenging Case of Heart Failure: Putting the Clues of ATTR-CM Together
Claudio Rapezzi discusses what should prompt suspicion of ATTR-CM in this patient and how suspicion can be confirmed through diagnostic techniques.
Cracked the Code: What to Do Next? A Treatment Option for Patients with ATTR-CM
Dr Thibaud Damy reviews the clinical data for a treatment option for ATTR-CM.
See other educational resources available
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. October 2020
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020